Johnson & Johnson Asks FDA To Authorize Vaccine

Johnson & Johnson has applied for emergency use authorization for its COVID vaccine, which requires only a single dose and can be stored in regular refrigerators. This vaccine is 66% effective against moderate and severe COVID cases, which is lower than Pfizer and Moderna's 95% efficacy. However, its logistical advantages and complete protection against hospitalizations and deaths 28 days post-vaccination make it a strong contender, especially for vaccinating hard-to-reach populations.

What new insight or understanding did you gain from this video?